152120-55-3 Usage
Description
N,N'-BIS-Z-1-GUANYLPYRAZOLE, also known as N,N'-Bis(benzyloxycarbonyl)-1H-pyrazole-1-carboxamidine, is a chemical compound with pharmaceutical applications. It is characterized by its off-white powder form and is primarily used as an intermediate in the synthesis of various pharmaceutical products.
Uses
Used in Pharmaceutical Industry:
N,N'-BIS-Z-1-GUANYLPYRAZOLE is used as a pharmaceutical intermediate for the development of various drugs. Its role in the pharmaceutical industry is crucial, as it serves as a building block in the synthesis of new and innovative medications that can potentially treat a wide range of medical conditions.
As a pharmaceutical intermediate, N,N'-BIS-Z-1-GUANYLPYRAZOLE is involved in the production of various drugs, including those that target specific diseases or conditions. Its chemical properties make it a valuable component in the development of new pharmaceuticals, contributing to the advancement of medical treatments and therapies.
Check Digit Verification of cas no
The CAS Registry Mumber 152120-55-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,2,1,2 and 0 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 152120-55:
(8*1)+(7*5)+(6*2)+(5*1)+(4*2)+(3*0)+(2*5)+(1*5)=83
83 % 10 = 3
So 152120-55-3 is a valid CAS Registry Number.
152120-55-3Relevant articles and documents
Diaminopyrimidines as P2X3 and P2X2/3 modulators
-
Page/Page column 17, (2008/12/08)
Compounds of formula (I): wherein R1 and R2 are as defined herein. Also disclosed are methods of making and using the subject compounds.
An efficient method for the preparation of ω,ω'-bis-urethane protected arginine derivatives
Wu,Matsueda,Bernatowicz
, p. 3055 - 3060 (2007/10/02)
Fmoc-Arg(ω,w')(Boc)2-OH and Boc-Arg(ω,w')(Cbz)2-OH were prepared in two steps: Guanylation of Cu(II)-ornithine complex at N(δ) with N,N'-bis urethane protected derivatives of 1-guanylpyrazole, followed by N(α)-protection using either 9-fluorenylmethyl succinimidylcarbonate or di-t-butyl-dicarbonate in the presence of EDTA. The overall yields of these products (2 steps) were 65% and 73%.